CRBU - Caribou Biosciences received IND clearance from FDA for its lupus treatment
2024-04-04 16:07:57 ET
More on Caribou Bioscience
- Caribou Biosciences: Under The Radar With Catalysts Approaching
- Biotech And Pharma Diversification Pays Off
- Caribou Bioscience GAAP EPS of -$0.39 in-line, revenue of $3.56M misses by $1.05M
- Seeking Alpha’s Quant Rating on Caribou Bioscience
- Historical earnings data for Caribou Bioscience